Matthew Lehman

Matthew Lehman

Chief Executive Officer at
Koligo Therapeutics, Inc.
49 year
Health Technology
Commercial Services
Consumer Services

Profile

Matthew B. Lehman is currently Chief Executive Officer at Koligo Therapeutics, Inc., and a member of the Association of Clinical Research Professionals and the European Business Association.
Formerly, Mr. Lehman was President, Chief Executive Officer & Director at Callitas Health, Inc. from 2015 to 2016; Chief Executive Officer, MD & Executive Director at Immutep Ltd. from 2013 to 2014; Chief Executive Officer & Executive Director at Koligo Therapeutics Ltd.; and Chief Operating Officer at SPRI Clinical Trials-Global LLC.
Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate studies at the University of Louisville.

Matthew Lehman active positions

CompaniesPositionStart
European Business Association
Corporate Officer/Principal 02/01/2011
Corporate Officer/Principal 02/01/2011
Chief Executive Officer -

Former positions of Matthew Lehman

CompaniesPositionEnd
Chief Executive Officer 17/02/2021
CALLITAS HEALTH INC. Chief Executive Officer 14/03/2016
IMMUTEP LIMITED Chief Executive Officer 08/07/2014
Chief Operating Officer -
See the detail of Matthew Lehman's experience

Training of Matthew Lehman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Commercial Services

Consumer Services

Health Technology

Consumer Services

Commercial Services

European Business Association

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Matthew Lehman